血浆高水平Gas6可预测老年患者静脉血栓栓塞复发、大出血与死亡:一项前瞻性多中心队列研究
该前瞻性多中心队列研究纳入864例≥65岁急性静脉血栓栓塞(VTE)患者,随访3年,于诊断时(T1)及其中70%患者12个月后(T2)检测血浆Gas6水平。诊断时Gas6>157%与VTE复发、大出血和死亡风险升高相关;T2时Gas6水平可区分T2后24个月内的VTE复发。
要点
- 诊断时Gas6>157%与6个月内VTE复发、大出血和死亡风险升高相关。
- 诊断时连续Gas6水平与12个月内VTE复发相关。
- T2时Gas6水平可区分T2后24个月内VTE复发。
核心结论
- 在老年患者中,高Gas6水平与VTE复发、大出血和死亡风险升高相关。
- 这些发现支持进一步研究评估Gas6在调整抗凝疗程中的表现。
研究设计与样本
- 前瞻性多中心队列研究,连续纳入≥65岁急性VTE患者,随访3年。
- 共864例患者在诊断时(T1)检测血浆Gas6,其中70%的患者在12个月后(T2)再次检测。
- 主要结局为症状性VTE复发、大出血和死亡,Gas6采用ELISA检测。
主要发现
- T1时Gas6水平对36个月内VTE复发的C统计量为0.56(95%CI 0.51-0.62),对大出血为0.60(95%CI 0.55-0.65),对死亡为0.69(95%CI 0.65-0.73)。
- T2时Gas6水平对T2后24个月内VTE复发的C统计量为0.62(95%CI 0.54-0.71)。
- T1时高Gas6水平(>157%)与6个月内VTE复发相关。
- T1时连续Gas6水平与12个月内VTE复发相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Essentials Predictive ability of pro-hemostatic Gas6 for recurrent venous thromboembolism (VTE) is unknown. We measured Gas6 levels in 864 patients with VTE over 3 years. High Gas6 (> 157%) at diagnosis is associated with VTE recurrence, major bleeding and mortality. Gas6 plasma levels measured 12 months after the index VTE are discriminatory for VTE recurrence. SUMMARY: Background Growth arrest-specific gene 6 (Gas6) is a prohemostatic protein with an unknown predictive ability for recurrent venous thromboembolism (VTE). In the elderly, VTE results in higher mortality but does not have a higher rate of recurrence than in younger patients. Consequently, anticoagulation management in the elderly is challenging. Objective To prospectively investigate the performance of Gas6 in predicting VTE recurrence, major bleeding and mortality in the elderly. Methods Consecutive patients aged ≥ 65 years with acute VTE were followed for a period of 3 years. Primary outcomes were symptomatic VTE recurrence, major bleeding, and mortality. Plasma Gas6 was measured with ELISA. Results Gas6 levels were measured in 864 patients at the time of the index VTE (T1) and, in 70% of them, also 12 months later (T2). The Gas6 level at T1 was discriminatory for VTE recurrence (C-statistic, 0.56; 95% confidence interval [CI] 0.51-0.62), major bleeding (0.60, 95% CI 0.55-0.65) and mortality (0.69, 95% CI 0.65-0.73) up to 36 months. VTE recurrence up to 24 months after T2 was discriminated by the Gas6 level at T2 (0.62, 95% CI 0.54-0.71). High Gas6 levels (> 157%) and continuous Gas6 levels at T1 were associated with VTE recurrence up to 6 months and 12 months, respectively. Conclusions In elderly patients, a high Gas6 level is associated with higher risks of VTE recurrence, major bleeding, and death. These findings support further studies to assess the performance of Gas6 in adjusting the length of anticoagulation.
引用
- Schnegg-Kaufmann A, Calzavarini S, Limacher A, et al. A high Gas6 level in plasma predicts venous thromboembolism recurrence, major bleeding and mortality in the elderly: a prospective multicenter cohort study. J Thromb Haemost. 2019. PMID: 30570809. doi:10.1111/jth.14365
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。